Email this article THE COMPARATIVE STUDYING OF ANTI-HYPOXEMIC ACTIVITY OF COMPLEX OF ZINC ACETATE WITH N-PROPARGYLIMIDAZOLE AND 3-HYDROXYPYRIDINE
- Authors: Shakhmardanova S.A1,2, Galenko-Yaroshevsky P.A2, Parshina L.N3, Trofimov B.A3, Tarasov V.V1, Maksimov M.L1, Sologova S.S1
-
Affiliations:
- The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia
- The Kubanskiy state medical university
- The A.E. Favorskiy Irkutskiy institute of chemistry of the Siberian branch of the Russian academy of sciences
- Issue: Vol 23, No 3 (2017)
- Pages: 148-151
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38401
- DOI: https://doi.org/10.18821/0869-2106-2017-23-3-148-151
- ID: 38401
Cite item
Full Text
Abstract
The pharmacotherapy of hypoxia is an important task of modern experimental and clinical pharmacology. The medications with anti-hypoxic effect implemented into clinical practice unfortunately do not meet requirements of physicians due to poor efficiency, narrow range of active dosages and undesirable side effects. The complexes of zinc with N-alkenylimidazole demonstrated anti-hypoxic activity at various models of acute hypoxia within large range of dosage. Therefore, further studying of zinc-contained compounds as possible correctors of hypoxia is of particular interest. The experiments with white nonlinear male mice were used for comparative investigation of ant-hypoxic effect of complex compounds of zinc acetate with N-propargylimidazole and 3-hydroxipyridine, including complexes immobilized on sulfated arabinogalaсtan and also well-known anti-hypoxants and/or anti-oxidants: etomerzol, mexidol, nooglutil and hypoxen. It is demonstrated that anti-hypoxic effect of complex of zinc acetate with N-propargylimidazolein conditions of acute hypobaric hypoxia, acute hypoxia with hypercapnia acute hematic hypoxia by width of active dosages (1-100 mg/kg, intraperitoneally) and degree of expression (19-317% in comparison with control groups of animals) excels the similar effect in well-known anti-hypoxants and/or anti-oxidants: etomerzol (25-100 mg/kg, intraperitoneally), mexidol (100 mk per kg, intraperitoneally), nooglutil (25-100 mg/kg, intraperitoneally) and hypoxen (50-150 mg/kg, intraperitoneally). The protective effect of complex of zinc acetate with 3-hydroxipyridine by width of active dosages (25-100 mg/kg, intraperitoneally) and degree of expression (27-167% in comparison with control groups of animals) in conditions of exogenous hypoxia (acute hypobaric hypoxia and acute hypoxia with hypercapnia) excels similar effect of etomerzol and mexidol ans is comparable with effect of nooglutil and hypoxen. The complexes immobilized on sulfated arabinogalactan were ineffective.
Full Text
##article.viewOnOriginalSite##About the authors
S. A Shakhmardanova
The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia; The Kubanskiy state medical university
Email: lebedeva502@yandex.ru
канд. биол. наук, доцент кафедры фармакологии ФГБОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России, 119991, Москва 119992, Moscow, Russian Federation; 350063, Krasnodar, Russian Federation
P. A Galenko-Yaroshevsky
The Kubanskiy state medical university350063, Krasnodar, Russian Federation
L. N Parshina
The A.E. Favorskiy Irkutskiy institute of chemistry of the Siberian branch of the Russian academy of sciences664033, Irkutsk, Russian Federation
B. A Trofimov
The A.E. Favorskiy Irkutskiy institute of chemistry of the Siberian branch of the Russian academy of sciences664033, Irkutsk, Russian Federation
V. V Tarasov
The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia119992, Moscow, Russian Federation
M. L Maksimov
The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia119992, Moscow, Russian Federation
S. S Sologova
The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia119992, Moscow, Russian Federation
References
- Самойлов Н.Н., Катунина Н.П., Лебедева С.А., Одринский П.Н., Бабаниязова З.Х., Петухова Н.Ф. и др. Изучение антигипоксической активности новых производных имидазола на модели гипоксии с гиперкапнией. Кубанский научный медицинский вестник. 2009; (8): 62-5.
- Стратиенко Е.Н., Богус С.К., Катунина Н.П., Свиридонова С.В., Егорова С.Е., Аверьянова С.А. и др. Изучение антигипоксической активности новых металлокомплексных соединений производных алкенилимидазола. Кубанский научный медицинский вестник. 2009; (8): 76-8.
- Шахмарданова С.А., Галенко-Ярошевский П.А. Металлокомплексные производные 1-алкенилимидазола. Антигипоксические свойства, механизмы действия, перспективы клинического применения. Краснодар: Просвещение-Юг; 2015.
- Kelleher S.L., McCormick N.H., Velasquez V., Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate and mammary gland. Adv. Nutr. 2011; 2 (2): 101-11.
- Malhotra A., Dhawan D.K. Current view of zinc as a hepatoprotective agent in conditions of chlorpyrifos induced toxicity. Pestic. Biochem. Physiol. 2014; 112: 1-6.
- Klug A. The discovery of zinc fingers and their development for practical applications in gene regulation and genome manipulation. Q. Rev. Biophys. 2010; 43 (1): 1-21.
- Brocard A., Dréno B. Innateimmunity: acrucial target for zinc in the treatment of inflammatory dermatosis. J. Eur. Acad. Dermatol. Venerol. 2011; 25 (10): 1146-52.
- Марри Р., Греннер Д., Мейес П., Родуэлл В. Биохимия человека. Т. 1. М.: Мир; 2004
- Harada T., Koyama I., Matsunaga T., Kikuno A., Kasahara T., Hassimoto M. et al. Characterization of structural and catalytic differences in rat intestinal alkaline phosphatase isozymes. FEBS J. 2005; 272 (10): 2477-86.
- Powell S.R. The antioxidant properties of zinc. J. Nutr. 2000; 130 (5S, Suppl.): 1447S-54S.
- Prasad A.S. Zinc in humans: health disordes and therapeutic effects. Mikroelementy v meditsine. 2014; 15 (1): 3-12.
- Thirumoorthy N., Manisenthil Kumar K.T., ShyamSundar A., Panayappan L., Chatterjee M. Metallothionein: an overview. World J. Gastroenterol. 2007; 13 (7): 993-6.
- Прасад А.С. Цинк для человека: терапевтическое действие и токсичность. Вопросы биологической, медицинской и фармацевтической химии. 2011; 9 (6): 9-13.
- Байкалова Л.В., Тарасова О.А., Зырянова И.А., Афонин А.В., Синеговская Л.М., Трофимов Б.А. Металлокомплексы 1-алленилимидазолов. Журнал общей химии. 2002; 72 (8): 1378-82.
- Зырянова И.А., Байкалова Л.В., Тарасова О.А., Афонин А.В., Кухарева В.А., Максимова М.А. и др. Комплексные соединения на основе 1-изопропенилимидазолов и пиразола. Журнал общей химии. 2005; 75 (8): 1353-9.
- Каркищенко Н.Н., Грачев С.В., ред. Руководство по лабораторным животным и альтернативным моделям в биомедицинских исследованиях. М.: Профиль-2С; 2010.
- Арзамасцев Е.В., Гуськова Т.А., Березовская И.В., Любимов Б.И., Либерман С.С., Верстакова О.Л. Методические указания по изучению общетоксического действия фармакологических веществ. В кн.: Хабриев Р.У., ред. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Медицина; 2005: 41-54.
- Березовская И.В. Классификация химических веществ по параметрам острой токсичности при парентеральных способах введения. Химико-фармацевтический журнал. 2003; 37 (3): 32-4.
